181 related articles for article (PubMed ID: 24881970)
21. Novel liver findings in ornithine transcarbamylase deficiency due to Xp11.4-p21.1 microdeletion.
Gallant NM; Gui D; Lassman CR; Yong WH; Teitell M; Mandelker D; Lorey F; Martinez-Agosto JA; Quintero-Rivera F
Gene; 2015 Feb; 556(2):249-53. PubMed ID: 25434494
[TBL] [Abstract][Full Text] [Related]
22. A case with combined rare inborn metabolic disorders: congenital adrenal hyperplasia and ornithine transcarbamylase deficiency.
Kim YM; Lee BH; Choi JH; Kim GH; Lim HH; Yoo HW
Gene; 2013 Sep; 527(1):394-6. PubMed ID: 23769969
[TBL] [Abstract][Full Text] [Related]
23. Urinary uracil in female patients with ornithine transcarbamylase deficiency.
Sumi S; Imaeda M; Ito T; Ueta A; Ban K; Ohkubo Y; Togari H
Pediatr Int; 2005 Jun; 47(3):262-6. PubMed ID: 15910448
[TBL] [Abstract][Full Text] [Related]
24. Ornithine transcarbamylase deficiency diagnosed in pregnancy.
Celik O; Buyuktas D; Aydin A; Acbay O
Gynecol Endocrinol; 2011 Dec; 27(12):1052-4. PubMed ID: 21736537
[TBL] [Abstract][Full Text] [Related]
25. Hyperammonemia in a Woman with Late-onset Ornithine Transcarbamylase Deficiency.
Koya Y; Shibata M; Senju M; Honma Y; Hiura M; Ishii M; Matsumoto S; Harada M
Intern Med; 2019 Apr; 58(7):937-942. PubMed ID: 30449781
[TBL] [Abstract][Full Text] [Related]
26. Altered neural activation in ornithine transcarbamylase deficiency during executive cognition: an fMRI study.
Gropman AL; Shattuck K; Prust MJ; Seltzer RR; Breeden AL; Hailu A; Rigas A; Hussain R; VanMeter J
Hum Brain Mapp; 2013 Apr; 34(4):753-61. PubMed ID: 22110002
[TBL] [Abstract][Full Text] [Related]
27. Advances in urea cycle neuroimaging: Proceedings from the 4th International Symposium on urea cycle disorders, Barcelona, Spain, September 2013.
Pacheco-Colón I; Fricke S; VanMeter J; Gropman AL
Mol Genet Metab; 2014; 113(1-2):118-26. PubMed ID: 25066103
[TBL] [Abstract][Full Text] [Related]
28. The phenotype of ostensibly healthy women who are carriers for ornithine transcarbamylase deficiency.
Maestri NE; Lord C; Glynn M; Bale A; Brusilow SW
Medicine (Baltimore); 1998 Nov; 77(6):389-97. PubMed ID: 9854602
[TBL] [Abstract][Full Text] [Related]
29. In Silico Analysis of a De Novo OTC Variant as a Cause of Ornithine Transcarbamylase Deficiency.
Ozdemir Y; Cag M; Gul S; Yüksel Z; Ergoren MC
Appl Immunohistochem Mol Morphol; 2022 Feb; 30(2):153-156. PubMed ID: 34670952
[TBL] [Abstract][Full Text] [Related]
30. Cerebral dysfunction in asymptomatic carriers of ornithine transcarbamylase deficiency.
Batshaw ML; Roan Y; Jung AL; Rosenberg LA; Brusilow SW
N Engl J Med; 1980 Feb; 302(9):482-5. PubMed ID: 7351973
[TBL] [Abstract][Full Text] [Related]
31. Genotype-Phenotype Correlations in Ornithine Transcarbamylase Deficiency: A Mutation Update.
Caldovic L; Abdikarim I; Narain S; Tuchman M; Morizono H
J Genet Genomics; 2015 May; 42(5):181-94. PubMed ID: 26059767
[TBL] [Abstract][Full Text] [Related]
32. Hyperammonemic coma in an ornithine transcarbamylase mutation carrier following antepartum corticosteroids.
Lipskind S; Loanzon S; Simi E; Ouyang DW
J Perinatol; 2011 Oct; 31(10):682-4. PubMed ID: 21956151
[TBL] [Abstract][Full Text] [Related]
33. Long-term treatment of girls with ornithine transcarbamylase deficiency.
Maestri NE; Brusilow SW; Clissold DB; Bassett SS
N Engl J Med; 1996 Sep; 335(12):855-9. PubMed ID: 8778603
[TBL] [Abstract][Full Text] [Related]
34. Prenatal treatment of ornithine transcarbamylase deficiency.
Wilnai Y; Blumenfeld YJ; Cusmano K; Hintz SR; Alcorn D; Benitz WE; Berquist WE; Bernstein JA; Castillo RO; Concepcion W; Cowan TM; Cox KL; Lyell DJ; Esquivel CO; Homeyer M; Hudgins L; Hurwitz M; Palma JP; Schelley S; Akula VP; Summar ML; Enns GM
Mol Genet Metab; 2018 Mar; 123(3):297-300. PubMed ID: 29396029
[TBL] [Abstract][Full Text] [Related]
35. Successful management of refractory intracranial hypertension from acute hyperammonemic encephalopathy in a woman with ornithine transcarbamylase deficiency.
Wendell LC; Khan A; Raser J; Lang SS; Malhotra N; Kofke WA; LeRoux P; Park S; Levine JM
Neurocrit Care; 2010 Aug; 13(1):113-7. PubMed ID: 20422467
[TBL] [Abstract][Full Text] [Related]
36. Activity of the liver enzyme ornithine carbamoyltransferase (OTC) in blood: LC-MS/MS assay for non-invasive diagnosis of ornithine carbamoyltransferase deficiency.
Krijt J; Sokolová J; Ješina P; Dvořáková L; Řeboun M; Brennerová K; Mistrík M; Zeman J; Honzík T; Kožich V
Clin Chem Lab Med; 2017 Jul; 55(8):1168-1177. PubMed ID: 28107167
[TBL] [Abstract][Full Text] [Related]
37. Ornithine transcarbamylase deficiency in females: an often overlooked cause of treatable encephalopathy.
Pridmore CL; Clarke JT; Blaser S
J Child Neurol; 1995 Sep; 10(5):369-74. PubMed ID: 7499756
[TBL] [Abstract][Full Text] [Related]
38. Heterozygote ornithine transcarbamylase deficiency presenting as symptomatic hyperammonemia during initiation of valproate therapy.
Honeycutt D; Callahan K; Rutledge L; Evans B
Neurology; 1992 Mar; 42(3 Pt 1):666-8. PubMed ID: 1549234
[TBL] [Abstract][Full Text] [Related]
39. Acute hyperammonemic encephalopathy in adult onset ornithine transcarbamylase deficiency.
Panlaqui OM; Tran K; Johns A; McGill J; White H
Intensive Care Med; 2008 Oct; 34(10):1922-4. PubMed ID: 18651132
[TBL] [Abstract][Full Text] [Related]
40. Hyperammonemic coma due to parenteral nutrition in a woman with heterozygous ornithine transcarbamylase deficiency.
Felig DM; Brusilow SW; Boyer JL
Gastroenterology; 1995 Jul; 109(1):282-4. PubMed ID: 7797025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
